MAZE · ISSUER CIK 1842295
Maze Therapeutics, Inc.
Between Aug 1, 2026 and Oct 29, 2026, 4 Maze Therapeutics, Inc. insiders reported $0.00 of open-market purchases and $5.9M of sales on SEC Form 4.
↗4 insiders filed
Original Form 4 filings from Aug 1, 2026 to Oct 29, 2026. 9 of 13 sales were reported under a 10b5-1 plan.
$0.00Insider buying
$5.9MInsider selling
−$5.9MNet open-market
Oct 2, 2026Latest filing
| Ticker | Insider | Type | Owned | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Oct 2, 202616:12 | Oct 1, 2026 | MAZE | Chief Executive Officer, Director | S · Sell10b5-1 | $27.02 | −34,501 | 191,447 | -15% | −$932K | ||
| Oct 2, 202616:09 | Oct 1, 2026 | MAZE | President, R&D & CMO | S · Sell10b5-1 | $26.93 | −16,141 | 0 | -100% | −$435K | ||
| Oct 2, 202616:09 | Oct 1, 2026 | MAZE | President, R&D & CMO | M · Exercise10b5-1 | $10.42 | +16,141 | 16,141 | New | $168K | ||
| Oct 1, 202616:06 | Sep 29, 2026 | MAZE | CSBO | S · Sell10b5-1 | $27.06 | −7,500 | 32,316 | -19% | −$203K | ||
| Oct 1, 202616:06 | Sep 29, 2026 | MAZE | CSBO | M · Exercise10b5-1 | $10.42 | +7,500 | 39,816 | +23% | $78K | ||
| Sep 8, 202616:20 | Sep 4, 2026 | MAZE | President, R&D & CMO | S · Sell10b5-1 | $26.22 | −9,705 | 0 | -100% | −$255K | ||
| Sep 4, 202616:27 | Sep 3, 2026from Sep 2, 2026 | MAZE | GC and Corp. Secretary | S · Sell | $26.24 | −3,993 | 7,007 | -36% | −$105K | ||
| Sep 4, 202616:25 | Sep 3, 2026from Sep 2, 2026 | MAZE | CSBO | S · Sell | $26.24 | −6,434 | 32,316 | -17% | −$169K | ||
| Sep 4, 202616:24 | Sep 3, 2026from Sep 2, 2026 | MAZE | Chief Executive Officer, Director | S · Sell | $26.24 | −22,638 | 27,362 | -45% | −$594K | ||
| Sep 4, 202616:22 | Sep 3, 2026from Sep 2, 2026 | MAZE | President, R&D & CMO | S · Sell | $26.24 | −10,295 | 9,705 | -51% | −$270K | ||
| Sep 3, 202616:31 | Sep 1, 2026 | MAZE | GC and Corp. Secretary | M · Exercise | — | +11,000 | 11,000 | New | — | ||
| Sep 3, 202616:29 | Sep 1, 2026 | MAZE | CSBO | M · Exercise | — | +12,500 | 38,750 | +48% | — | ||
| Sep 3, 202616:27 | Sep 1, 2026 | MAZE | Chief Executive Officer, Director | S · Sell10b5-1 | $26.29 | −34,501 | 223,355 | -13% | −$907K | ||
| Sep 3, 202616:27 | Sep 1, 2026 | MAZE | Chief Executive Officer, Director | M · Exercise10b5-1 | — | +50,000 | 50,000 | New | — | ||
| Sep 3, 202616:24 | Sep 1, 2026 | MAZE | President, R&D & CMO | S · Sell10b5-1 | $26.36 | −16,141 | 0 | -100% | −$426K | ||
| Sep 3, 202616:24 | Sep 1, 2026 | MAZE | President, R&D & CMO | M · Exercise10b5-1 | $4.65 | +36,141 | 20,000 | — | $168K | ||
| Aug 31, 202618:32 | Aug 28, 2026 | MAZE | CSBO | S · Sell10b5-1 | $27.58 | −7,500 | 26,250 | -22% | −$207K | ||
| Aug 31, 202618:32 | Aug 28, 2026 | MAZE | CSBO | M · Exercise10b5-1 | $10.42 | +7,500 | 33,750 | +29% | $78K | ||
| Aug 14, 202616:54 | Aug 13, 2026 | MAZE | President, R&D & CMO | S · Sell10b5-1 | $27.61 | −16,142 | 0 | -100% | −$446K | ||
| Aug 14, 202616:54 | Aug 13, 2026 | MAZE | President, R&D & CMO | M · Exercise10b5-1 | $10.42 | +16,142 | 16,142 | New | $168K | ||
| Aug 5, 202616:08 | Aug 3, 2026 | MAZE | Chief Executive Officer, Director | S · Sell10b5-1 | $26.73 | −34,501 | 255,263 | -12% | −$922K |